S. Vickers

1.1k total citations
31 papers, 919 citations indexed

About

S. Vickers is a scholar working on Pharmacology, Organic Chemistry and Surgery. According to data from OpenAlex, S. Vickers has authored 31 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Organic Chemistry and 6 papers in Surgery. Recurrent topics in S. Vickers's work include Pharmacogenetics and Drug Metabolism (8 papers), Lipoproteins and Cardiovascular Health (5 papers) and Metabolism and Genetic Disorders (4 papers). S. Vickers is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Lipoproteins and Cardiovascular Health (5 papers) and Metabolism and Genetic Disorders (4 papers). S. Vickers collaborates with scholars based in United States, Canada and Japan. S. Vickers's co-authors include D E Duggan, C A Duncan, Avery Rosegay, Byron H. Arison, Harri G. Ramjit, Kamlesh P. Vyas, Michael S. Schwartz, P H Kari, Steven M. Pitzenberger and Rita A. Halpin and has published in prestigious journals such as Analytical Chemistry, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

S. Vickers

31 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Vickers United States 14 282 256 227 164 142 31 919
C A Duncan United States 8 225 0.8× 169 0.7× 179 0.8× 142 0.9× 116 0.8× 13 601
Jamie J. Zhao United States 16 322 1.1× 172 0.7× 166 0.7× 138 0.8× 123 0.9× 28 985
Shimoga R. Prakash United States 16 125 0.4× 741 2.9× 210 0.9× 99 0.6× 235 1.7× 41 1.2k
Bennett Ma United States 16 489 1.7× 356 1.4× 616 2.7× 194 1.2× 467 3.3× 38 1.6k
Donald Pinto United States 28 304 1.1× 513 2.0× 202 0.9× 159 1.0× 147 1.0× 58 3.5k
Ulf Bredberg Sweden 21 160 0.6× 454 1.8× 352 1.6× 262 1.6× 621 4.4× 33 1.9k
Donald E. Slaughter United States 10 122 0.4× 111 0.4× 242 1.1× 70 0.4× 140 1.0× 12 583
Miroslav Dostálek United States 22 111 0.4× 542 2.1× 367 1.6× 68 0.4× 226 1.6× 45 1.6k
Anuradha S. Pappu United States 25 688 2.4× 638 2.5× 29 0.1× 34 0.2× 150 1.1× 50 1.5k
Michelle W. Kloss United States 12 106 0.4× 149 0.6× 229 1.0× 30 0.2× 42 0.3× 17 658

Countries citing papers authored by S. Vickers

Since Specialization
Citations

This map shows the geographic impact of S. Vickers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Vickers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Vickers more than expected).

Fields of papers citing papers by S. Vickers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Vickers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Vickers. The network helps show where S. Vickers may publish in the future.

Co-authorship network of co-authors of S. Vickers

This figure shows the co-authorship network connecting the top 25 collaborators of S. Vickers. A scholar is included among the top collaborators of S. Vickers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Vickers. S. Vickers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vickers, S., Donghui Cui, Raju Subramanian, et al.. (2006). METABOLISM AND DISPOSITION OF A POTENT AND SELECTIVE GABA-Aα2/3 RECEPTOR AGONIST IN HEALTHY MALE VOLUNTEERS. Drug Metabolism and Disposition. 34(6). 1004–1011. 9 indexed citations
3.
Vickers, S., et al.. (2000). The Biotransformation of Nitrogen Containing Xenobiotics to Lactams. Current Drug Metabolism. 1(4). 357–389. 41 indexed citations
4.
Vickers, S., Anthony D. Theoharides, Byron H. Arison, et al.. (1999). In Vitro and In Vivo Studies on the Metabolism of Tirofiban. Drug Metabolism and Disposition. 27(11). 1360–1366. 32 indexed citations
5.
Cheng, Hsien C., Michael S. Schwartz, S. Vickers, et al.. (1994). Metabolic disposition of simvastatin in patients with T-tube drainage.. Drug Metabolism and Disposition. 22(1). 139–142. 33 indexed citations
6.
Vickers, S., et al.. (1994). Disposition of MK-852, a fibrinogen receptor antagonist, in rats and dogs.. Drug Metabolism and Disposition. 22(4). 631–636. 3 indexed citations
7.
Vickers, S., C A Duncan, P H Kari, et al.. (1993). In vivo and in vitro metabolism studies on a class III antiarrhythmic agent.. Drug Metabolism and Disposition. 21(3). 467–473. 9 indexed citations
8.
Quérin, Serge, Raymond Lambert, Jean R. Cusson, et al.. (1991). Single-dose pharmacokinetics of 14C-lovastatin in chronic renal failure. Clinical Pharmacology & Therapeutics. 50(4). 437–441. 20 indexed citations
9.
Vickers, S. & C A Duncan. (1991). Studies on the metabolic inversion of the 6′ chiral center or simvastatin. Biochemical and Biophysical Research Communications. 181(3). 1508–1515. 3 indexed citations
10.
Duggan, D E & S. Vickers. (1990). Physiological Disposition of Hmg-Coa-Reductase Inhibitors. Drug Metabolism Reviews. 22(4). 333–362. 62 indexed citations
11.
Vickers, S., C A Duncan, Kamlesh P. Vyas, et al.. (1990). In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.. Drug Metabolism and Disposition. 18(4). 476–483. 136 indexed citations
12.
Duggan, D E, W.F. Bayne, Rita A. Halpin, et al.. (1989). The physiological disposition of lovastatin.. Drug Metabolism and Disposition. 17(2). 166–173. 102 indexed citations
13.
Vyas, Kamlesh P., P H Kari, S. Vickers, et al.. (1988). Metabolism of simvastatin s by rat and mouse liver microsomes. The FASEB Journal. 2(5). 4444. 1 indexed citations
14.
Vickers, S., Charles A. Duncan, Harri G. Ramjit, et al.. (1984). Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester.. Drug Metabolism and Disposition. 12(2). 242–246. 6 indexed citations
15.
Vickers, S., et al.. (1978). EVALUATION OF SUCCINIMIDOETHYL AND PIVALOYLOXYETHYL ESTERS AS PROGENITORS OF METHYLDOPA IN MAN, RHESUS MONKEY, DOG, AND RAT. Drug Metabolism and Disposition. 6(6). 640–646. 21 indexed citations
16.
Vickers, S., et al.. (1975). Metabolism of carbidopa, (-)-L-.alpha.-hydrazino-3,4-dihydroxy-.alpha.-methylbenzenepropanoic acid monohydrate, in the human, rhesus monkey, dog, and rat. Journal of Medicinal Chemistry. 18(2). 134–138. 26 indexed citations
17.
18.
Vickers, S., et al.. (1974). Simple, sensitive spectrophotofluorometric method for hydrazine in plasma. Analytical Chemistry. 46(1). 138–139. 10 indexed citations
19.
20.
Hampshire, Jennifer, P. Hebborn, A. M. Triggle, David J. Triggle, & S. Vickers. (1965). Potential Folic Acid Antagonists. I. The Antitumor and Folic Acid Reductase Inhibitory Properties of 6-Substituted 2,4-Diamino-5-arylazopyrimidines1. Journal of Medicinal Chemistry. 8(6). 745–749. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C A Duncan Breakdown of academic impact, for papers by Jamie J. Zhao Breakdown of academic impact, for papers by Shimoga R. Prakash Breakdown of academic impact, for papers by Bennett Ma Breakdown of academic impact, for papers by Donald Pinto Breakdown of academic impact, for papers by Ulf Bredberg Breakdown of academic impact, for papers by Donald E. Slaughter Breakdown of academic impact, for papers by Miroslav Dostálek Breakdown of academic impact, for papers by Anuradha S. Pappu Breakdown of academic impact, for papers by Michelle W. Kloss
Rankless by CCL
2026